Pain News and Research

Latest Pain News and Research

FDA approves New Drug Application for PENNSA 2%

Mallinckrodt today announced that the U.S. Food and Drug Administration has approved the New Drug Application for PENNSAID (diclofenac sodium topical solution) 2% w/w. PENNSAID 2% is a topical non-steroidal anti-inflammatory drug approved for use in the treatment of the pain of osteoarthritis of the knee(s).

17 Jan 2014

Patient's EMR coupled with pharmacist intervention improves preventative care of shingles

While people over the age of 60 account for more than half of all shingles cases, less than 15% get the vaccination that helps prevent the blistering skin rash, which can cause lingering nerve pain.

17 Jan 2014

Single stem cell injection after meniscus knee surgery may provide pain relief, aid in meniscus regrowth

A single stem cell injection following meniscus knee surgery may provide pain relief and aid in meniscus regrowth, according to a novel study appearing in the January issue of the Journal of Bone and Joint Surgery (JBJS).

17 Jan 2014

Vitamin D may be adjunct for patients with fibromyalgia syndrome, say researchers

Patients with fibromyalgia syndrome (FMS) typically have widespread chronic pain and fatigue. For those with low vitamin D levels, vitamin D supplements can reduce pain and may be a cost-effective alternative or adjunct to other treatment, say researchers in the January 2014 issue of PAIN-.

17 Jan 2014

Viewpoints: Mass. abortion debate comes down to 35 feet; Tampa mayor leads charge to get young people signed up for health care

The First Amendment protects the speech of short, elderly women and large and intimidating men equally, but you would be forgiven for thinking otherwise after oral arguments before the Supreme Court Wednesday morning.

17 Jan 2014

Heritage announces availability of Prochlorperazine Edisylate Injection

Heritage Pharmaceuticals Inc. announced the immediate availability of Prochlorperazine Edisylate Injection in the 5mg/mL strength.

16 Jan 2014

RoundTable Healthcare Partners sells Aqua Pharmaceuticals Holdings for $402.6M to Almirall

RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has completed the sale of Aqua Pharmaceuticals Holdings, Inc. to Almirall S.A. for up to $402.6 million in cash

16 Jan 2014

Researchers develop "smart" hydrogel that can deliver medicine on demand

Researchers at the University of Delaware have developed a "smart" hydrogel that can deliver medicine on demand, in response to mechanical force.

16 Jan 2014

FDA accepts Iroko Pharmaceuticals' ZORVOLEX sNDA for review

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced that the U.S. Food and Drug Administration has accepted for review the Supplemental New Drug Application for ZORVOLEX (diclofenac), a lower dose nonsteroidal anti-inflammatory drug, for the proposed indication of treatment of osteoarthritis pain in adults. ZORVOLEX was approved by FDA in October 2013 for the treatment of mild to moderate acute pain in adults.

15 Jan 2014

Brain's structure is related to how intensely people perceive pain, say scientists

Everybody feels pain differently, and brain structure may hold the clue to these differences. In a study published in the current online issue of the journal Pain, scientists at Wake Forest Baptist Medical Center have shown that the brain's structure is related to how intensely people perceive pain.

15 Jan 2014

University of Washington develops new device to move kidney stones inside body

Almost one in 10 people will someday experience a kidney stone, which creates what is described as the most intense pain imaginable. This increasingly common condition leads to hundreds of thousands of surgeries in the United States each year.

13 Jan 2014

Obesity interferes with blood pressure control

Patients who are overweight or obese have a high risk for uncontrolled blood pressure, despite often taking multiple antihypertensive agents, say researchers.

13 Jan 2014

Nonsurgical treatment improves symptoms in women with pelvic floor dysfunction

One in three women suffer from pelvic floor dysfunction, a range of symptoms which include bladder and bowel problems as well as pelvic pain, according to the American Urogynecologic Society. Now, University of Missouri researchers have demonstrated that a comprehensive, nonsurgical treatment significantly improves symptoms in women with PFD.

10 Jan 2014

Researchers develop automated venipuncture device that automates phlebotomy procedure

A new medical device has been developed that will provide phlebotomists and clinicians with a technology to enable blood drawing accuracy at first stick. This is particularly important considering the diverse patient demographic each with various levels of difficult venous access.

10 Jan 2014

FDA approves Ocular Therapeutix’s ReSure Sealant for ophthalmic use

Ocular Therapeutix announced today it has received approval from the Food and Drug Administration to commercialize the ReSure Sealant in the United States, with an indication for prevention of postoperative fluid egress from incisions with a demonstrated wound leak following cataract surgery.

10 Jan 2014

Undergraduate students develop innovative, non-X-ray device that evaluates spinal movement

Those have undergone extensive back surgery and need repeated X-rays to monitor their progress may soon have access to a new technology that skips the X-rays and repeated radiation exposure, opting instead for an innovative, noninvasive, non-X-ray device that evaluates spinal movement.

10 Jan 2014

Aetna is helping to reverse abuse of prescription painkillers

Abuse of prescription painkillers, known as opioids, is a widespread and growing problem in the United States. The epidemic adds billions of dollars to health care, work place and criminal justice costs each year.

10 Jan 2014

Trevena doses first patient in TRV027 Phase 2b trial for acute heart failure

Trevena, Inc., a clinical stage pharmaceutical company involved in the discovery and development of G-protein coupled receptor biased ligands, announced today initiation of dosing in BLAST-AHF, the Company's randomized, multi-center Phase 2b trial of TRV027 in patients with acute heart failure.

9 Jan 2014

Biogen Idec, Sangamo BioSciences partner to develop therapeutics for hemoglobinopathies

Biogen Idec and Sangamo BioSciences, Inc. announced today an exclusive worldwide collaboration and license agreement focused on the development of therapeutics for hemoglobinopathies, inherited conditions that result from the abnormal structure or underproduction of hemoglobin.

9 Jan 2014

Auxilium Pharmaceuticals reports interim data from XIAFLEX Phase 4 study in patients with DC

Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced that interim data from its Phase 4 retreatment study (AUX-CC-862) evaluating XIAFLEX (collagenase clostridium histolyticum or CCH) in adult patients with Dupuytren's contracture and a recurrent contracture with a palpable cord will be presented for the first time at the American Association for Hand Surgery 2014 Annual Meeting being held January 8-11, 2014 in Kauai, Hawaii.

9 Jan 2014

Pain News and Research

Latest Pain News and Research

FDA approves New Drug Application for PENNSA 2%

Patient's EMR coupled with pharmacist intervention improves preventative care of shingles

Single stem cell injection after meniscus knee surgery may provide pain relief, aid in meniscus regrowth

Vitamin D may be adjunct for patients with fibromyalgia syndrome, say researchers

Viewpoints: Mass. abortion debate comes down to 35 feet; Tampa mayor leads charge to get young people signed up for health care

Heritage announces availability of Prochlorperazine Edisylate Injection

RoundTable Healthcare Partners sells Aqua Pharmaceuticals Holdings for $402.6M to Almirall

Researchers develop "smart" hydrogel that can deliver medicine on demand

FDA accepts Iroko Pharmaceuticals' ZORVOLEX sNDA for review

Brain's structure is related to how intensely people perceive pain, say scientists

University of Washington develops new device to move kidney stones inside body

Obesity interferes with blood pressure control

Nonsurgical treatment improves symptoms in women with pelvic floor dysfunction

Researchers develop automated venipuncture device that automates phlebotomy procedure

FDA approves Ocular Therapeutix’s ReSure Sealant for ophthalmic use

Undergraduate students develop innovative, non-X-ray device that evaluates spinal movement

Aetna is helping to reverse abuse of prescription painkillers

Trevena doses first patient in TRV027 Phase 2b trial for acute heart failure

Biogen Idec, Sangamo BioSciences partner to develop therapeutics for hemoglobinopathies

Auxilium Pharmaceuticals reports interim data from XIAFLEX Phase 4 study in patients with DC

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Pain News and Research

Latest Pain News and Research

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in